APA

Kahen E. J., Brohl A., Yu D., Welch D., Cubitt C. L., Lee J. K., Chen Y., Yoder S. J., Teer J. K., Zhang Y. O., Wallace M. R. & Reed D. R. (2018). Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors. : Oncotarget.

Chicago

Kahen Elliot John, Brohl Andrew, Yu Diana, Welch Darcy, Cubitt Christopher L, Lee Jae K, Chen Yunyun, Yoder Sean J, Teer Jamie K, Zhang Yonghong O, Wallace Margaret R and Reed Damon R. 2018. Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors. : Oncotarget.

Harvard

Kahen E. J., Brohl A., Yu D., Welch D., Cubitt C. L., Lee J. K., Chen Y., Yoder S. J., Teer J. K., Zhang Y. O., Wallace M. R. and Reed D. R. (2018). Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors. : Oncotarget.

MLA

Kahen Elliot John, Brohl Andrew, Yu Diana, Welch Darcy, Cubitt Christopher L, Lee Jae K, Chen Yunyun, Yoder Sean J, Teer Jamie K, Zhang Yonghong O, Wallace Margaret R and Reed Damon R. Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors. : Oncotarget. 2018.